全文获取类型
收费全文 | 24522篇 |
免费 | 1522篇 |
国内免费 | 583篇 |
专业分类
耳鼻咽喉 | 105篇 |
儿科学 | 438篇 |
妇产科学 | 309篇 |
基础医学 | 5909篇 |
口腔科学 | 453篇 |
临床医学 | 1338篇 |
内科学 | 3115篇 |
皮肤病学 | 540篇 |
神经病学 | 1369篇 |
特种医学 | 525篇 |
外国民族医学 | 4篇 |
外科学 | 1924篇 |
综合类 | 3407篇 |
现状与发展 | 1篇 |
一般理论 | 1篇 |
预防医学 | 941篇 |
眼科学 | 197篇 |
药学 | 2985篇 |
7篇 | |
中国医学 | 1477篇 |
肿瘤学 | 1582篇 |
出版年
2024年 | 68篇 |
2023年 | 326篇 |
2022年 | 468篇 |
2021年 | 749篇 |
2020年 | 793篇 |
2019年 | 692篇 |
2018年 | 631篇 |
2017年 | 737篇 |
2016年 | 728篇 |
2015年 | 788篇 |
2014年 | 1436篇 |
2013年 | 1753篇 |
2012年 | 1415篇 |
2011年 | 1747篇 |
2010年 | 1402篇 |
2009年 | 1488篇 |
2008年 | 1351篇 |
2007年 | 1266篇 |
2006年 | 1195篇 |
2005年 | 975篇 |
2004年 | 882篇 |
2003年 | 780篇 |
2002年 | 618篇 |
2001年 | 460篇 |
2000年 | 468篇 |
1999年 | 383篇 |
1998年 | 417篇 |
1997年 | 321篇 |
1996年 | 392篇 |
1995年 | 303篇 |
1994年 | 283篇 |
1993年 | 211篇 |
1992年 | 190篇 |
1991年 | 124篇 |
1990年 | 72篇 |
1989年 | 60篇 |
1988年 | 35篇 |
1987年 | 20篇 |
1986年 | 31篇 |
1985年 | 90篇 |
1984年 | 81篇 |
1983年 | 47篇 |
1982年 | 67篇 |
1981年 | 43篇 |
1980年 | 44篇 |
1979年 | 35篇 |
1978年 | 35篇 |
1977年 | 23篇 |
1976年 | 33篇 |
1975年 | 25篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
121.
122.
Murata K Inami M Hasegawa A Kubo S Kimura M Yamashita M Hosokawa H Nagao T Suzuki K Hashimoto K Shinkai H Koseki H Taniguchi M Ziegler SF Nakayama T 《International immunology》2003,15(8):987-992
CD69, known as an early activation marker antigen on T and B cells, is also expressed on platelets and activated neutrophils, suggesting certain roles in inflammatory diseases. In order to address the role of CD69 in the pathogenesis of arthritis, we established CD69-null mice. CD69-null mice displayed a markedly attenuated arthritic inflammatory response when injected with anti-type II collagen antibodies. Cell transfer experiments with neutrophils, but not T cells or spleen cells, from wild-type mice into CD69-null mice restored the induction of arthritis. These results indicate a critical role for CD69 in neutrophil function in arthritis induction during the effector phase. Thus, CD69 would be a possible therapeutic target for arthritis in human patients. 相似文献
123.
124.
Kiyonori Miura Hideaki Masuzaki Tadayuki Ishimaru Norio Niikawa Y. Jinno 《Journal of human genetics》1998,43(4):283-284
We found a HhaI/BstUI polymorphism in the 3′ untranslated region of a novel gene which was localized to 11p15.5. This region is one of prominent
imprinting domains and contains multiple imprinted genes, such as H19, IGF2 , KVLQT1, and p57
KIP2
, which suggests that regional factors might contribute to the imprinting.
This polymorphism will be useful in the allelic analysis of expression and methylation of the novel gene.
Received: July 24, 1998 / Accepted: July 29, 1998 相似文献
125.
In this report, we describe the identification of a human leucocyte antigen-A*11 (HLA-A*11) nucleotide sequence variant, a new HLA-A*1120 by using sequence-based typing (SBT). The new allele was detected during routine HLA typing by high-resolution SBT. Allele A*1120 showed one nucleotide difference with A*110101 at codon 152 (GCG-->GAG) resulting in an amino acid change from alanine to glutamate. Residue 152 is located on alpha(2)-helix of HLA class I molecule and involved in peptide binding by constructing E pocket of peptide-binding groove, implying that the change of the residue 152 would affect the binding affinity of peptides to A*1120 allele. 相似文献
126.
Kerr PJ Perkins HD Inglis B Stagg R McLaughlin E Collins SV Van Leeuwen BH 《Virology》2004,324(1):117-128
Rabbit IL-4 was expressed in the virulent standard laboratory strain (SLS) and the attenuated Uriarra (Ur) strain of myxoma virus with the aim of creating a Th2 cytokine environment and inhibiting the development of an antiviral cell-mediated response to myxomatosis in infected rabbits. This allowed testing of a model for genetic resistance to myxomatosis in wild rabbits that have undergone 50 years of natural selection for resistance to myxomatosis. Expression of IL-4 significantly enhanced virulence of both virulent and attenuated virus strains in susceptible (laboratory) and resistant (wild) rabbits. SLS-IL-4 completely overcame genetic resistance in wild rabbits. The pathogenesis of SLS-IL-4 was compared in susceptible and resistant rabbits. The results support a model for resistance to myxomatosis of an enhanced innate immune response controlling virus replication and allowing an effective antiviral cell-mediated immune response to develop in resistant rabbits. Expression of IL-4 did not overcome immunity to myxomatosis induced by immunization. 相似文献
127.
Allergen immunotherapy induces a suppressive memory response mediated by IL-10 in a mouse asthma model 总被引:2,自引:0,他引:2
Vissers JL van Esch BC Hofman GA Kapsenberg ML Weller FR van Oosterhout AJ 《The Journal of allergy and clinical immunology》2004,113(6):235-1210
BACKGROUND: Human studies have demonstrated that allergen immunotherapy induces memory suppressive responses and IL-10 production by allergen-specific T cells. Previously, we established a mouse model in which allergen immunotherapy was effective in the suppression of allergen-induced asthma manifestations. OBJECTIVE: In this study, we examined whether immunotherapy induces a long-lasting effect and investigated the role of IL-10 in successful immunotherapy. METHODS: Ovalbumin-sensitized BALB/c mice were treated with 3 injections of ovalbumin (1 mg, subcutaneous) on alternate days. After a short interval (1 week) and after a long interval (5 weeks), mice were challenged by ovalbumin inhalation, and subsequently, airway reactivity, airway eosinophilia, ovalbumin-specific IgE, and T(H)2 cytokine profile were measured. Flow cytometry and blocking of IL-10 receptors in vivo were used to gain insight in the role of IL-10 in the beneficial effects of allergen immunotherapy. RESULTS: After a long interval between ovalbumin immunotherapy and ovalbumin challenge, the development of airway eosinophilia and hyperresponsiveness to methacholine were as strongly suppressed as after a short interval. These suppressive effects coincided with significantly reduced serum ovalbumin-specific IgE levels and T(H)2 cytokine production. On immunotherapy, the IL-5:IL-10 ratio in the bronchoalveolar lavage fluid shifted toward IL-10. In ovalbumin-restimulated lung cell and thoracic lymph node cultures from these mice, IL-5 levels dramatically decreased, whereas the percentage of IL-10(+)CD4(+) T cells was not affected. Finally, in mice treated with mAb against IL-10 receptors, the beneficial effects of immunotherapy were largely abrogated. CONCLUSION: These data demonstrate that allergen immunotherapy induces a memory suppressive effect in which IL-10 is essential. 相似文献
128.
Kawano T Matsuse H Kondo Y Machida I Saeki S Tomari S Mitsuta K Fukushima C Obase Y Shimoda T Kohno S 《The Journal of allergy and clinical immunology》2004,114(6):398-1281
BACKGROUND: The exact mechanism of aspirin-induced asthma is not clear. It has been postulated that precipitation of asthma attacks by aspirin is linked to inhibition of COX activity and massive release of cysteinyl leukotriene into the airway. Tacrolimus, a macrolide-derived immunosuppressant, is used for immunosuppression in organ transplantation and also for allergic diseases such as atopic dermatitis. OBJECTIVE: We evaluated the effects of tacrolimus in aspirin-induced asthma by using a double-blind, crossover study design. METHODS: Twelve patients with aspirin-induced asthma (male:female, 3:9; mean age +/- SD, 36.7 +/- 7.2 years) received either tacrolimus (0.1 mg/kg) or placebo 2 hours before the threshold dose of oral aspirin. RESULTS: In the placebo arm, oral aspirin significantly decreased FEV 1 concomitant with significant increases in sputum eosinophilic cationic protein and urinary leukotriene E(4) levels. Tacrolimus significantly inhibited bronchoconstriction and abrogated aspirin-induced increase in both sputum eosinophilic cationic protein and urinary leukotriene E(4) levels. CONCLUSION: The current study suggested that tacrolimus inhibited bronchoconstriction to a threshold dose of aspirin by inhibition of cysteinyl leukotriene excretion. 相似文献
129.
In this review, we have summarized our work using combined complex statistical genetics, bioinformatics, and functional genomics to determine the genetic basis of the age-related thymic involution in C57BL/6J X DBA/2J recombinant inbred mice and the parental B6 and D2 mice. We have shown that these mice provided a valuable genetic model that can permit resampling of thymuses from different aged but genetically identical animals and determination of the relative significance of age-associated changes in the thymus. Our results suggest that the quantitative trait loci (QTL) regulating the Con A-induced thymocyte proliferative response were mapped to mouse chromosome Chr 11 (D11Mit51 at 18 cM), a region that harbors the IL-12b gene. The importance of IL-12b in maintaining thymic integrity and function during the aging process was confirmed by a more rapid involution of the thymus in IL-12b knockout (IL-12b-/-) mice compared to wild-type (WT) mice. Functionally, IL-12 provided a strong synergistic effect to augment the IL-7 or IL-2 induced thymocyte proliferative response, especially in both aged WT and IL-12b-/- mice, but not in normal young mice. In contract to the proliferative response, the age-related decline in the total number of thymocytes was determined at different age, and mapped to loci on Chr 9, 62 cM and Chr 10, 32 cM. Using matrix-assisted laser desorption/ionisation-time of flight-mass spectrometry (MALDI-TOF-MS), increased expression of peroxiredoxin was found to be correlated with thymic involution. Our results suggest the possibility to identify the complex molecular network that can be associated with the regulation of thymic involution in aged mice using a high-dimensional functional genomics approach. 相似文献
130.
Takahashi HK Xue D Iwagaki H Tamura R Katsuno G Yagi T Yoshino T Mori S Nishibori M Tanaka N 《Clinical immunology (Orlando, Fla.)》2005,115(1):85-92
Prostaglandin E1 (PGE1) has therapeutic value for transplantations due to its microvascular activity. Interleukin (IL)-18, which is elevated in plasma during the acute rejection after organ transplantation, elicits the expression of intercellular adhesion molecule (ICAM)-1, B7.1, B7.2, CD40, and CD40 ligand (CD40L) on monocytes as well as the production of interferon (IFN)-gamma and IL-12 and proliferation of T-cells during the human mixed lymphocyte reaction (MLR) in an in vitro model of acute rejection. In contrast, PGE1 inhibits all the adhesion molecule expression, cytokine production and T-cell proliferation in the presence of IL-18. The effects of PGE1 depend on stimulation of the IP/EP2/EP4-receptor, and thus, PGE1 might have therapeutic potential for treating acute rejection due to its immune regulatory effect. 相似文献